127 related articles for article (PubMed ID: 17521951)
1. Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver.
Liao YC; Lo SH
Int J Biochem Cell Biol; 2008; 40(5):843-7. PubMed ID: 17521951
[TBL] [Abstract][Full Text] [Related]
2. DLC-1:a Rho GTPase-activating protein and tumour suppressor.
Durkin ME; Yuan BZ; Zhou X; Zimonjic DB; Lowy DR; Thorgeirsson SS; Popescu NC
J Cell Mol Med; 2007; 11(5):1185-207. PubMed ID: 17979893
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of the Dlc1 gene cooperates with downregulation of p15INK4b and p16Ink4a, leading to neoplastic transformation and poor prognosis in human cancer.
Qian X; Durkin ME; Wang D; Tripathi BK; Olson L; Yang XY; Vass WC; Popescu NC; Lowy DR
Cancer Res; 2012 Nov; 72(22):5900-11. PubMed ID: 23010077
[TBL] [Abstract][Full Text] [Related]
4. A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors.
Low JS; Tao Q; Ng KM; Goh HK; Shu XS; Woo WL; Ambinder RF; Srivastava G; Shamay M; Chan AT; Popescu NC; Hsieh WS
Oncogene; 2011 Apr; 30(16):1923-35. PubMed ID: 21217778
[TBL] [Abstract][Full Text] [Related]
5. DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms.
Healy KD; Hodgson L; Kim TY; Shutes A; Maddileti S; Juliano RL; Hahn KM; Harden TK; Bang YJ; Der CJ
Mol Carcinog; 2008 May; 47(5):326-37. PubMed ID: 17932950
[TBL] [Abstract][Full Text] [Related]
6. The role of tensins in malignant neoplasms.
Nizioł M; Pryczynicz A
Arch Med Sci; 2023; 19(5):1382-1397. PubMed ID: 37732046
[TBL] [Abstract][Full Text] [Related]
7. Loci for insulin processing and secretion provide insight into type 2 diabetes risk.
Broadaway KA; Yin X; Williamson A; Parsons VA; Wilson EP; Moxley AH; Vadlamudi S; Varshney A; Jackson AU; Ahuja V; Bornstein SR; Corbin LJ; Delgado GE; Dwivedi OP; Fernandes Silva L; Frayling TM; Grallert H; Gustafsson S; Hakaste L; Hammar U; Herder C; Herrmann S; Højlund K; Hughes DA; Kleber ME; Lindgren CM; Liu CT; Luan J; Malmberg A; Moissl AP; Morris AP; Perakakis N; Peters A; Petrie JR; Roden M; Schwarz PEH; Sharma S; Silveira A; Strawbridge RJ; Tuomi T; Wood AR; Wu P; Zethelius B; Baldassarre D; Eriksson JG; Fall T; Florez JC; Fritsche A; Gigante B; Hamsten A; Kajantie E; Laakso M; Lahti J; Lawlor DA; Lind L; März W; Meigs JB; Sundström J; Timpson NJ; Wagner R; Walker M; Wareham NJ; Watkins H; Barroso I; O'Rahilly S; Grarup N; Parker SC; Boehnke M; Langenberg C; Wheeler E; Mohlke KL
Am J Hum Genet; 2023 Feb; 110(2):284-299. PubMed ID: 36693378
[TBL] [Abstract][Full Text] [Related]
8. TNS1: Emerging Insights into Its Domain Function, Biological Roles, and Tumors.
Wang Z; Ye J; Dong F; Cao L; Wang M; Sun G
Biology (Basel); 2022 Oct; 11(11):. PubMed ID: 36358270
[TBL] [Abstract][Full Text] [Related]
9.
Tan Y; Lo SH
Genes Dis; 2022 May; 9(3):814-819. PubMed ID: 35782987
[TBL] [Abstract][Full Text] [Related]
10. Role of Constitutive STAR in Leydig Cells.
Galano M; Li Y; Li L; Sottas C; Papadopoulos V
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670702
[TBL] [Abstract][Full Text] [Related]
11. Endothelial YAP/TAZ Signaling in Angiogenesis and Tumor Vasculature.
Hooglugt A; van der Stoel MM; Boon RA; Huveneers S
Front Oncol; 2020; 10():612802. PubMed ID: 33614496
[TBL] [Abstract][Full Text] [Related]
12. Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.
Cao Y; Xie L; Shi F; Tang M; Li Y; Hu J; Zhao L; Zhao L; Yu X; Luo X; Liao W; Bode AM
Signal Transduct Target Ther; 2021 Jan; 6(1):15. PubMed ID: 33436584
[TBL] [Abstract][Full Text] [Related]
13. Frequent Downregulation and Promoter Hypermethylation of DLC1: Relationship with Clinical Outcome in Gallbladder Cancer.
Singh D; Bharti A; Biswas D; Tewari M; Kar AG; Ansari MA; Singh S; Narayan G
J Gastrointest Cancer; 2022 Jun; 53(2):237-244. PubMed ID: 33417200
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of rho GTPases during lung adenocarcinoma migration and invasion reveals a novel role of the tumor suppressor StarD13 in invadopodia regulation.
Al Haddad M; El-Rif R; Hanna S; Jaafar L; Dennaoui R; Abdellatef S; Miskolci V; Cox D; Hodgson L; El-Sibai M
Cell Commun Signal; 2020 Sep; 18(1):144. PubMed ID: 32900380
[TBL] [Abstract][Full Text] [Related]
15. Nuclear DLC1 exerts oncogenic function through association with FOXK1 for cooperative activation of MMP9 expression in melanoma.
Yang X; Hu F; Liu JA; Yu S; Cheung MPL; Liu X; Ng IO; Guan XY; Wong KKW; Sharma R; Lung HL; Jiao Y; Lee LTO; Cheung M
Oncogene; 2020 May; 39(20):4061-4076. PubMed ID: 32214200
[TBL] [Abstract][Full Text] [Related]
16. IQGAP1 activates PLC-δ1 by direct binding and moving along microtubule with DLC-1 to cell surface.
Tanaka M; Osanai T; Homma Y; Hanada K; Okumura K; Tomita H
FASEB Bioadv; 2019 Aug; 1(8):465-480. PubMed ID: 32123844
[TBL] [Abstract][Full Text] [Related]
17. Salivary epigenetic biomarkers as predictors of emerging childhood obesity.
Rushing A; Sommer EC; Zhao S; Po'e EK; Barkin SL
BMC Med Genet; 2020 Feb; 21(1):34. PubMed ID: 32059710
[TBL] [Abstract][Full Text] [Related]
18. A Hierarchical Machine Learning Model to Discover Gleason Grade-Specific Biomarkers in Prostate Cancer.
Hamzeh O; Alkhateeb A; Zheng JZ; Kandalam S; Leung C; Atikukke G; Cavallo-Medved D; Palanisamy N; Rueda L
Diagnostics (Basel); 2019 Dec; 9(4):. PubMed ID: 31835700
[TBL] [Abstract][Full Text] [Related]
19. DLC1 deficiency and YAP signaling drive endothelial cell contact inhibition of growth and tumorigenesis.
Ritchey L; Ha T; Otsuka A; Kabashima K; Wang D; Wang Y; Lowy DR; Tosato G
Oncogene; 2019 Nov; 38(45):7046-7059. PubMed ID: 31409902
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
